Tapewire

NYSE · USD

ELAN

Elanco Animal Health Inc

Export transactions ↓
Tapewire entity
3457
SEC CIK
0001739104
Parsed reports
704

Last 12 months

Inside the activity.

11 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202540
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202650
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 4, 2023 02:09 UTC
YOUNG TODD S.SEE REMARKS
Tax withholdingCommon Stock 5,600 $11.26 $63,056.00
Disclosure

SEC source: 0001415889-23-004288 · form4-03042023_020326.xml · nonDerivative · entry 1

YOUNG TODD S. · CIK 0001682584 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,349

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:08 UTC GrantEmployee Stock Option (right to buy) · Derivative 60,700 $0.00 Strike: $11.26 $0.00
Disclosure

SEC source: 0001415889-23-004287 · form4-03042023_020319.xml · derivative · entry 4

Urbanek David Alan · CIK 0001752446 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,700

Underlying: Common Stock · 60,700 shares

Expires 2033-03-01

F4 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:08 UTC GrantCommon Stock 26,577 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004287 · form4-03042023_020319.xml · nonDerivative · entry 2

Urbanek David Alan · CIK 0001752446 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,012

F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:08 UTC Tax withholdingCommon Stock 2,923 $11.26 $32,912.98
Disclosure

SEC source: 0001415889-23-004287 · form4-03042023_020319.xml · nonDerivative · entry 1

Urbanek David Alan · CIK 0001752446 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,435

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:06 UTC GrantEmployee Stock Option (right to buy) · Derivative 86,207 $0.00 Strike: $11.26 $0.00
Disclosure

SEC source: 0001415889-23-004285 · form4-03042023_020304.xml · derivative · entry 4

Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,207

Underlying: Common Stock · 86,207 shares

Expires 2033-03-01

F4 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:06 UTC GrantCommon Stock 37,745 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004285 · form4-03042023_020304.xml · nonDerivative · entry 2

Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,196

F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:06 UTC Tax withholdingCommon Stock 3,490 $11.26 $39,297.40
Disclosure

SEC source: 0001415889-23-004285 · form4-03042023_020304.xml · nonDerivative · entry 1

Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,451

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:00 UTC GrantEmployee Stock Option (right to buy) · Derivative 76,065 $0.00 Strike: $11.26 $0.00
Disclosure

SEC source: 0001415889-23-004282 · form4-03042023_020342.xml · derivative · entry 3

Kirberger Marcela A. · CIK 0001868881 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,065

Underlying: Common Stock · 76,065 shares

Expires 2033-03-01

F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:00 UTC GrantCommon Stock 33,304 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004282 · form4-03042023_020342.xml · nonDerivative · entry 2

Kirberger Marcela A. · CIK 0001868881 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,884

F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:00 UTC Tax withholdingCommon Stock 1,707 $11.26 $19,220.82
Disclosure

SEC source: 0001415889-23-004282 · form4-03042023_020342.xml · nonDerivative · entry 1

Kirberger Marcela A. · CIK 0001868881 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,580

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:59 UTC GrantEmployee Stock Option (right to buy) · Derivative 103,550 $0.00 Strike: $11.26 $0.00
Disclosure

SEC source: 0001415889-23-004281 · form4-03042023_010345.xml · derivative · entry 3

de Brabander Ellen · CIK 0001892179 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,550

Underlying: Common Stock · 103,550 shares

Expires 2033-03-01

F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:59 UTC GrantCommon Stock 45,338 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004281 · form4-03042023_010345.xml · nonDerivative · entry 2

de Brabander Ellen · CIK 0001892179 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,806

F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:59 UTC Tax withholdingCommon Stock 2,368 $11.26 $26,663.68
Disclosure

SEC source: 0001415889-23-004281 · form4-03042023_010345.xml · nonDerivative · entry 1

de Brabander Ellen · CIK 0001892179 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,468

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:58 UTC
Meer James MCHIEF ACCOUNTING OFFICER
GrantCommon Stock 8,659 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004279 · form4-03042023_010313.xml · nonDerivative · entry 2

Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,902

F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:58 UTC
Meer James MCHIEF ACCOUNTING OFFICER
Tax withholdingCommon Stock 673 $11.26 $7,577.98
Disclosure

SEC source: 0001415889-23-004279 · form4-03042023_010313.xml · nonDerivative · entry 1

Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,243

F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:55 UTC
Modi Rajeev A.SEE REMARKS
GrantEmployee Stock Option (right to buy) · Derivative 53,246 $0.00 Strike: $11.26 $0.00
Disclosure

SEC source: 0001415889-23-004278 · form4-03042023_010334.xml · derivative · entry 2

Modi Rajeev A. · CIK 0001916473 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,246

Underlying: Common Stock · 53,246 shares

Expires 2033-03-01

F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:55 UTC
Modi Rajeev A.SEE REMARKS
GrantCommon Stock 23,313 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004278 · form4-03042023_010334.xml · nonDerivative · entry 1

Modi Rajeev A. · CIK 0001916473 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,355

F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

F2 · balance_after: Includes 1,885 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan between September 30, 2022 and December 30, 2022.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:06 UTC
YOUNG TODD S.SEE REMARKS
ConversionTangible Equity Units · Derivative 1,562 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-001921 · form4-02032023_090246.xml · derivative · entry 4

YOUNG TODD S. · CIK 0001682584 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

F1 · derivative.exercise_date: Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

F1 · derivative.expiration_date: Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:06 UTC
YOUNG TODD S.SEE REMARKS
ConversionCommon Stock 1,562 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-001921 · form4-02032023_090246.xml · nonDerivative · entry 1

YOUNG TODD S. · CIK 0001682584 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 6,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 23:32 UTC
Meer James MCHIEF ACCOUNTING OFFICER
Tax withholdingCommon Stock 402 $12.35 $4,964.70
Disclosure

SEC source: 0001415889-23-000585 · form4-01052023_110159.xml · nonDerivative · entry 7

Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,916

F5 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:09 UTC GrantDeferred Stock Units · Derivative 750.1367 $12.22 $9,166.67
Disclosure

SEC source: 0001415889-23-000091 · form4-01032023_100126.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,214.568

Underlying: Common Stock · 750.1367 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:08 UTC GrantDeferred Stock Units · Derivative 722.8584 $12.22 $8,833.33
Disclosure

SEC source: 0001415889-23-000089 · form4-01032023_100159.xml · derivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,487.3487

Underlying: Common Stock · 722.8584 shares

Expires not disclosed

F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:10 UTC GrantDeferred Stock Units · Derivative 872.8863 $12.22 $10,666.67
Disclosure

SEC source: 0001415889-23-000093 · form4-01032023_100141.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,820.4684

Underlying: Common Stock · 872.8863 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:08 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011977 · form4-12022022_101229.xml · nonDerivative · entry 1

Kochevar Deborah Turner · CIK 0001448579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,857

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:12 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011981 · form4-12022022_101213.xml · nonDerivative · entry 1

Herendeen Paul · CIK 0001374175 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,956

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:04 UTC GrantDeferred Stock Units · Derivative 712.251 $12.87 $9,166.67
Disclosure

SEC source: 0001415889-22-011972 · form4-12022022_101203.xml · derivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,464.4313

Underlying: Common Stock · 712.251 shares

Expires not disclosed

F2 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F3 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:04 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011972 · form4-12022022_101203.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,916

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:07 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011975 · form4-12022022_101209.xml · nonDerivative · entry 1

Scots-Knight Denise · CIK 0001297000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,857

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:03 UTC GrantDeferred Stock Units · Derivative 686.3504 $12.87 $8,833.33
Disclosure

SEC source: 0001415889-22-011971 · form4-12022022_101218.xml · derivative · entry 3

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,764.4903

Underlying: Common Stock · 686.3504 shares

Expires not disclosed

F2 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F3 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:03 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011971 · form4-12022022_101218.xml · nonDerivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,857

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:10 UTC
GARCIA ART ADirector
GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011979 · form4-12022022_101255.xml · nonDerivative · entry 1

GARCIA ART A · CIK 0001183585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,421

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:05 UTC GrantDeferred Stock Units · Derivative 828.8011 $12.87 $10,666.67
Disclosure

SEC source: 0001415889-22-011973 · form4-12022022_101200.xml · derivative · entry 4

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,947.5821

Underlying: Common Stock · 828.8011 shares

Expires not disclosed

F2 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:05 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011973 · form4-12022022_101200.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,916

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:10 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011980 · form4-12022022_101236.xml · nonDerivative · entry 1

DOYLE WILLIAM F · CIK 0001194459 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,956

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:07 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011976 · form4-12022022_101247.xml · nonDerivative · entry 1

McDonald Kirk P · CIK 0001517740 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,857

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:09 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011978 · form4-12022022_101208.xml · nonDerivative · entry 1

Harrington Michael J · CIK 0001566340 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,120

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:06 UTC GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011974 · form4-12022022_101211.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,116

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 11, 2022 Filed Nov 15, 2022 21:40 UTC PurchaseCommon Stock 7,500 $13.24 $99,267.00
Disclosure

SEC source: 0001415889-22-011397 · form4-11152022_091113.xml · nonDerivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 41,722

F1 · price: Reflects the weighted average price of 7,500 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 11, 2022 with purchase prices ranging from $13.22 to $13.27 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 22:45 UTC Tax withholdingCommon Stock 11,295 $13.28 $149,997.60
Disclosure

SEC source: 0001415889-22-011075 · form4-11032022_031132.xml · nonDerivative · entry 1

de Brabander Ellen · CIK 0001892179 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,836

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:27 UTC GrantDeferred Stock Units · Derivative 694.9712 $13.19 $9,166.67
Disclosure

SEC source: 0001415889-22-010995 · form4-11022022_011133.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,752.1803

Underlying: Common Stock · 694.9712 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:32 UTC GrantDeferred Stock Units · Derivative 669.699 $13.19 $8,833.33
Disclosure

SEC source: 0001415889-22-011004 · form4-11022022_011109.xml · derivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,078.1399

Underlying: Common Stock · 669.699 shares

Expires not disclosed

F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:29 UTC GrantDeferred Stock Units · Derivative 808.6937 $13.19 $10,666.67
Disclosure

SEC source: 0001415889-22-010998 · form4-11022022_011111.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,118.781

Underlying: Common Stock · 808.6937 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:51 UTC GrantDeferred Stock Units · Derivative 738.6519 $12.41 $9,166.67
Disclosure

SEC source: 0001415889-22-010280 · form4-10042022_021057.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,057.2091

Underlying: Common Stock · 738.6519 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:54 UTC GrantDeferred Stock Units · Derivative 711.7913 $12.41 $8,833.33
Disclosure

SEC source: 0001415889-22-010281 · form4-10042022_021043.xml · derivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,408.4409

Underlying: Common Stock · 711.7913 shares

Expires not disclosed

F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:50 UTC GrantDeferred Stock Units · Derivative 859.5222 $12.41 $10,666.67
Disclosure

SEC source: 0001415889-22-010279 · form4-10042022_021006.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,310.0873

Underlying: Common Stock · 859.5222 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 09, 2022 Filed Sep 9, 2022 20:30 UTC
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
PurchaseCommon Stock 30,000 $14.54 $436,146.00
Disclosure

SEC source: 0001415889-22-009497 · form4-09092022_010908.xml · nonDerivative · entry 1

Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 30,000

F1 · price: Reflects the weighted average price of 30,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on September 9, 2022 with purchase prices ranging from $14.42 to $14.5576 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
September 09, 2022 Filed Sep 9, 2022 20:29 UTC PurchaseCommon Stock 10,000 $15.03 $150,250.00
Disclosure

SEC source: 0001415889-22-009495 · form4-09092022_010955.xml · nonDerivative · entry 1

Herendeen Paul · CIK 0001374175 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,307

Read SEC document
September 09, 2022 Filed Sep 9, 2022 20:31 UTC PurchaseCommon Stock 20,000 $15.18 $303,614.00
Disclosure

SEC source: 0001415889-22-009498 · form4-09092022_010912.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 145,000

F1 · shares: Reflects the weighted average price of 20,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on September 9, 2022 with purchase prices ranging from $15.105 to $15.2599 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
September 09, 2022 Filed Sep 9, 2022 20:29 UTC
Modi Rajeev A.SEE REMARKS
PurchaseCommon Stock 6,700 $14.90 $99,830.00
Disclosure

SEC source: 0001415889-22-009496 · form4-09092022_010935.xml · nonDerivative · entry 1

Modi Rajeev A. · CIK 0001916473 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,157

Read SEC document
August 31, 2022 Filed Sep 2, 2022 20:06 UTC GrantDeferred Stock Units · Derivative 605.8605 $15.13 $9,166.67
Disclosure

SEC source: 0001415889-22-009257 · form4-09022022_010919.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,318.5572

Underlying: Common Stock · 605.8605 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.